Tzu-Hao Chang Selected Research

Drug Therapy (Chemotherapy)

12/2021	miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.
1/2021	Collagen type VI regulates the CDK4/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis.
1/2015	Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tzu-Hao Chang Research Topics

Disease

18	Neoplasms (Cancer) 06/2023 - 01/2015
5	Fibrosis (Cirrhosis) 09/2023 - 05/2015
5	Ovarian Neoplasms (Ovarian Cancer) 06/2023 - 01/2015
5	Ovarian Epithelial Carcinoma 06/2023 - 01/2021
5	Chronic Renal Insufficiency 11/2022 - 01/2014
4	Carcinogenesis 01/2020 - 01/2015
4	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2018 - 05/2015
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2018
2	Osteoporosis 05/2023 - 01/2022
2	Rhinosinusitis 12/2022 - 11/2019
2	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 01/2014
2	Disease Progression 01/2022 - 06/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2015
2	Infections 01/2022 - 12/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2017
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 03/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Ischemic Stroke 01/2021 - 01/2015
2	Lymphatic Metastasis 01/2019 - 03/2018
2	Papillomavirus Infections 11/2018 - 01/2018
2	Aortic Valve Disease 01/2018 - 01/2016
2	Heart Failure 01/2018 - 11/2016
2	Stroke (Strokes) 01/2015 - 01/2014
1	Atrioventricular Block 09/2023
1	Non-alcoholic Fatty Liver Disease 07/2023
1	Lactic Acidosis 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Arteriovenous Fistula 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Adenocarcinoma 01/2022
1	Thrombosis (Thrombus) 12/2021
1	Prostatic Neoplasms (Prostate Cancer) 05/2021
1	COVID-19 01/2021
1	Hemorrhage 01/2021
1	Colonic Neoplasms (Colon Cancer) 06/2020
1	Glioma (Gliomas) 03/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
8	MicroRNAs (MicroRNA)IBA 06/2023 - 01/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2015
5	Collagen Type XIIBA 06/2023 - 12/2017
5	Messenger RNA (mRNA)IBA 06/2023 - 11/2016
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
2	UbiquitinIBA 06/2023 - 02/2023
2	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 02/2023
2	MethyltransferasesIBA 06/2023 - 02/2023
2	Raloxifene Hydrochloride (Evista)FDA Link 05/2023 - 01/2022
2	Teriparatide (Parathar)FDA Link 05/2023 - 01/2022
2	Denosumab FDA Link 05/2023 - 01/2022
2	Diphosphonates (Bisphosphonates)IBA 05/2023 - 01/2022
2	EnzymesIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2020
2	InterleukinsIBA 06/2020 - 01/2020
2	LipidsIBA 01/2019 - 12/2018
2	Angiotensin IIIBA 01/2018 - 05/2015
1	Sirtuin 1IBA 09/2023
1	Indicators and Reagents (Reagents)IBA 07/2023
1	16S Ribosomal RNAIBA 12/2022
1	Metformin (Glucophage)FDA LinkGeneric 11/2022
1	AminoglycosidesIBA 10/2022
1	Estrone FDA Link 01/2022
1	VaccinesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	PlatinumIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	LectinsIBA 01/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Circular RNAIBA 01/2022
1	LaxativesIBA 01/2022
1	SphingolipidsIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 10/2021
1	ribociclibIBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	CollagenIBA 01/2021
1	Moclobemide (Arima)IBA 01/2021
1	Collagen Type VIIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 06/2020
1	CateninsIBA 06/2020
1	Leucine (L-Leucine)FDA Link 06/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2020
1	Adenosine Triphosphate (ATP)IBA 06/2020
1	Fluorouracil (Carac)FDA LinkGeneric 06/2020
1	Janus KinasesIBA 06/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019
1	CytokinesIBA 01/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2014
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2015
1	Liver Transplantation 07/2023
1	Renal Dialysis (Hemodialysis) 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Intravenous Injections 01/2021
1	Endoscopes 11/2019